Cancer test with saliva Insurance major invests in investment Product development that reduces insurance premiums is also August 23 0:00
Major life insurance companies and non-life insurance companies have invested in venture companies that have developed testing technologies that can examine cancer risks from a small amount of saliva. For those who have been inspected, we plan to consider developing new insurance products that will reduce insurance premiums.
The major life insurance company Nippon Life and the non-life insurance company SOMPO Holdings are planning to invest several hundred million yen each this month in a venture company in Yamagata Prefecture, which was established by a research institute at Keio University.
Venture companies have developed testing techniques that can be used to determine whether there is a suspicion of cancer by collecting a small amount of saliva and are being used in medical institutions around the world.
Nippon Life and SOMPO Holdings are planning to consider the development of new life insurance and medical insurance that will reduce insurance premiums if they are regularly inspected.
If cancer can be detected early through testing, it will be useful for policyholders, and insurance companies can expect to increase their profits by reducing insurance payments.
Recently, “health promotion” insurance, which discounts insurance premiums for people who take health checkups and exercise to prevent disease, is popular, and insurance companies are also focusing on product development.